|
TOMM34 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
3.71360053819103E-10 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.11022302462516E-16 |
| Stage1-vs-Stage2 |
9.422600E-01 |
| Stage1-vs-Stage3 |
2.802600E-01 |
| Stage1-vs-Stage4 |
1.497410E-01 |
| Stage2-vs-Stage3 |
5.273200E-01 |
| Stage2-vs-Stage4 |
2.904600E-01 |
| Stage3-vs-Stage4 |
5.919600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62447832963153E-12 |
| Normal-vs-AfricanAmerican |
1.60380000002736E-06 |
| Normal-vs-Asian |
1.62470037423645E-12 |
| Caucasian-vs-AfricanAmerican |
9.690400E-01 |
| Caucasian-vs-Asian |
3.830800E-01 |
| AfricanAmerican-vs-Asian |
5.301000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
1.372220E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
<1E-12 |
| Normal-vs-Age(41-60Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(61-80Yrs) |
<1E-12 |
| Normal-vs-Age(81-100Yrs) |
2.089900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.354000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.660800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.359200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.046220E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.857370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.522000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.234500E-02 |
| Classical-VS-Follicular |
1.88737914186277E-15 |
| Classical-VS-Other |
5.286200E-01 |
| Classical-VS-Normal |
1.62436730732907E-12 |
| Tall-VS-Follicular |
9.80310277398644E-11 |
| Tall-VS-Other |
3.084600E-01 |
| Tall-VS-Normal |
1.62458935193399E-12 |
| Follicular-VS-Other |
1.168420E-01 |
| Follicular-VS-Normal |
4.77200000004174E-06 |
| Other-VS-Normal |
5.925800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
2.90020230053756E-11 |
| N0-vs-N1 |
3.586400E-01 |
|
|
